Analysts' Top Industrial Goods Picks: Brookfield Business Partners (BBU), AFRY AB Class B (AFXXF)
Stay Ahead of the Market:
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Brookfield Business Partners (BBU)
In a report issued on April 24, Robert Kwan from RBC Capital maintained a Buy rating on Brookfield Business Partners, with a price target of $30.00. The company's shares closed last Friday at $21.69.
According to TipRanks.com, Kwan is ranked #124 out of 9437 analysts.
Brookfield Business Partners has an analyst consensus of Strong Buy, with a price target consensus of $31.00, representing a 43.7% upside. In a report issued on April 24, Scotiabank also maintained a Buy rating on the stock with a $29.00 price target.
AFRY AB Class B (AFXXF)
In a report issued on April 24, Anders Jafs from Kepler Capital maintained a Buy rating on AFRY AB Class B, with a price target of SEK233.00. The company's shares closed last Thursday at $18.33, equals to its 52-week low of $18.33.
Jafs has an average return of 11.2% when recommending AFRY AB Class B.
According to TipRanks.com, Jafs is ranked #2625 out of 9437 analysts.
AFRY AB Class B has an analyst consensus of Moderate Buy, with a price target consensus of $25.10, which is a 37.0% upside from current levels. In a report issued on April 24, Jefferies also maintained a Buy rating on the stock with a SEK250.00 price target.
Verisk Analytics (VRSK)
RBC Capital analyst Ashish Sabadra maintained a Buy rating on Verisk Analytics on April 24 and set a price target of $314.00. The company's shares closed last Friday at $286.05.
According to TipRanks.com, Sabadra is a 4-star analyst with an average return of 3.6% and a 53.8% success rate. Sabadra covers the Financial sector, focusing on stocks such as Dun & Bradstreet Holdings, Intercontinental Exchange, and Cboe Global Markets.
Verisk Analytics has an analyst consensus of Moderate Buy, with a price target consensus of $313.33, implying an 8.9% upside from current levels. In a report issued on April 9, Robert W. Baird also maintained a Buy rating on the stock with a $320.00 price target.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
7 hours ago
- Business Insider
Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO), Resmed (RMD) and Envista Holdings (NVST)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bausch + Lomb Corporation (BLCO – Research Report), Resmed (RMD – Research Report) and Envista Holdings (NVST – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bausch + Lomb Corporation (BLCO) J.P. Morgan analyst Robbie Marcus maintained a Hold rating on Bausch + Lomb Corporation on July 30 and set a price target of $13.00. The company's shares closed last Friday at $13.50, close to its 52-week low of $13.16. According to Marcus is a 4-star analyst with an average return of 8.8% and a 52.8% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Zimmer Biomet Holdings, and Merit Medical Systems. Bausch + Lomb Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $14.69, implying an 8.2% upside from current levels. In a report issued on July 30, Needham also maintained a Hold rating on the stock. Resmed (RMD) J.P. Morgan analyst David Low maintained a Buy rating on Resmed yesterday and set a price target of $310.00. The company's shares closed last Friday at $279.20. According to Low is a 4-star analyst with an average return of 7.6% and a 57.0% success rate. Low covers the Healthcare sector, focusing on stocks such as Fisher & Paykel Healthcare Corporation Limited, Cochlear, and CSL. Resmed has an analyst consensus of Strong Buy, with a price target consensus of $295.40, implying a 4.8% upside from current levels. In a report released yesterday, KeyBanc also maintained a Buy rating on the stock with a $298.00 price target. Envista Holdings (NVST) J.P. Morgan analyst Rachel Vatnsdal maintained a Hold rating on Envista Holdings yesterday and set a price target of $20.00. The company's shares closed last Friday at $20.83. According to Vatnsdal is a 1-star analyst with an average return of -1.2% and a 39.3% success rate. Vatnsdal covers the Healthcare sector, focusing on stocks such as Caris Life Sciences, Inc., Twist Bioscience, and Myriad Genetics. Envista Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $22.17, which is a 9.6% upside from current levels. In a report issued on July 29, UBS also maintained a Hold rating on the stock with a $22.00 price target.
Business Insider
7 hours ago
- Business Insider
Analysts' Opinions Are Mixed on These Financial Stocks: Lendingtree (TREE), Flagstar Financial (FLG) and Houlihan Lokey (HLI)
Analysts have been eager to weigh in on the Financial sector with new ratings on Lendingtree (TREE – Research Report), Flagstar Financial (FLG – Research Report) and Houlihan Lokey (HLI – Research Report). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Lendingtree (TREE) J.P. Morgan analyst Melissa Wedel maintained a Buy rating on Lendingtree yesterday and set a price target of $66.00. The company's shares closed last Friday at $49.47. According to Wedel is a 4-star analyst with an average return of 10.5% and a 67.1% success rate. Wedel covers the Financial sector, focusing on stocks such as MidCap Financial Investment Corporation, Blackstone Secured Lending Fund, and Sixth Street Specialty Lending. Lendingtree has an analyst consensus of Strong Buy, with a price target consensus of $66.40, implying a 37.3% upside from current levels. In a report issued on July 24, KBW also maintained a Buy rating on the stock with a $66.00 price target. Flagstar Financial (FLG) J.P. Morgan analyst Anthony Elian maintained a Hold rating on Flagstar Financial on July 31 and set a price target of $12.50. The company's shares closed last Friday at $11.20. According to Elian has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -6.7% and a 32.0% success rate. Elian covers the Financial sector, focusing on stocks such as Zions Bancorporation National Association, Pinnacle Financial Partners, and First Citizens BancShares. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Flagstar Financial with a $13.45 average price target, representing a 19.6% upside. In a report issued on July 28, TR | OpenAI – 4o also initiated coverage with a Hold rating on the stock with a $11.50 price target. Houlihan Lokey (HLI) J.P. Morgan analyst Ken Worthington maintained a Hold rating on Houlihan Lokey on July 30 and set a price target of $197.00. The company's shares closed last Friday at $189.79, close to its 52-week high of $192.10. According to Worthington is a 4-star analyst with an average return of 2.9% and a 52.9% success rate. Worthington covers the Financial sector, focusing on stocks such as Intercontinental Exchange, Apollo Global Management, and Victory Capital Holdings. Houlihan Lokey has an analyst consensus of Moderate Buy, with a price target consensus of $197.17.
Yahoo
11 hours ago
- Yahoo
Verisk Analytics (VRSK) Fell Along with Other Defensive Stocks in Q2
Baron Funds, an investment management company, released its 'Baron Asset Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. stocks rose amid volatility caused by tariff policies and Middle East tensions. Early April risk-off sentiment was fueled by Trump's 'Liberation Day' tariffs, seen as more severe than expected. U.S. equities rose after April 8, driven by favorable trade news, strong earnings, dovish Fed signals, and AI momentum, reaching record highs by quarter's end. During the second quarter, the fund was up 7.85% (Institutional Shares) compared to an 18.20% gain for the Russell Midcap Growth Index. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Baron Asset Fund highlighted stocks such as Verisk Analytics, Inc. (NASDAQ:VRSK). Verisk Analytics, Inc. (NASDAQ:VRSK) offers data analytics and technology solutions to the insurance industry. The one-month return of Verisk Analytics, Inc. (NASDAQ:VRSK) was -8.34%, and its shares gained 4.52% of their value over the last 52 weeks. On July 31, 2025, Verisk Analytics, Inc. (NASDAQ:VRSK) stock closed at $278.71 per share, with a market capitalization of $38.94 billion. Baron Asset Fund stated the following regarding Verisk Analytics, Inc. (NASDAQ:VRSK) in its second quarter 2025 investor letter: "Verisk Analytics, Inc. (NASDAQ:VRSK) stock lagged alongside other defensive stocks during the quarter. There was no materially negative company specific news in the period. Verisk reported solid Q1 2025 earnings and CEO Lee Shavel sounded upbeat about the company's growth potential. We maintain conviction in the competitive positioning, long-term growth, margin expansion, and capital deployment prospects for the business." An engineer using the latest predictive analytics software to formulate solutions. Verisk Analytics, Inc. (NASDAQ:VRSK) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held Verisk Analytics, Inc. (NASDAQ:VRSK) at the end of the first quarter, which was 40 in the previous quarter. In the second quarter of 2025, Verisk Analytics, Inc. (NASDAQ:VRSK) generated $773 million in revenue, representing an increase of 7.8% from Q2 2024. While we acknowledge the potential of Verisk Analytics, Inc. (NASDAQ:VRSK) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Verisk Analytics, Inc. (NASDAQ:VRSK) and shared Fidelity Growth Strategies Fund's views on the company in the previous quarter. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
